共 105 条
[1]
Gillen S(2010)Preoperative/neoadjuvant therapy in pancreatic cancer: a systematic review and meta-analysis of response and resection percentages PLoS Med. 7 e1000267-745
[2]
Schuster T(2012)Developments in metastatic pancreatic cancer: is gemcitabine still the standard? World J Gastroenterol. 18 736-29
[3]
Meyer Zum Buschenfelde C(2014)Cancer statistics, 2014 CA Cancer J Clin. 64 9-947
[4]
Friess H(2008)Full-dose gemcitabine with concurrent radiation therapy in patients with nonmetastatic pancreatic cancer: a multicenter phase II trial J Clin Oncol. 26 942-158
[5]
Kleeff J(2012)A phase II study of oral S-1 with concurrent radiotherapy followed by chemotherapy with S-1 alone for locally advanced pancreatic cancer J Hepatobiliary Pancreat Sci. 19 152-1097
[6]
Ying JE(2016)Preoperative gemcitabine-based chemoradiation therapy for borderline resectable pancreatic cancer: impact of venous and arterial involvement status on surgical outcome and pattern of recurrence Ann Surg. 264 1091-1344
[7]
Zhu LM(2010)The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes Science. 330 1340-674
[8]
Liu BX(2011)Hallmarks of cancer: the next generation Cell. 144 646-314
[9]
Siegel R(1956)On the origin of cancer cells Science. 123 309-5594
[10]
Ma J(2012)Targeting hypoxia, HIF-1, and tumor glucose metabolism to improve radiotherapy efficacy Clin Cancer Res. 18 5585-662